Wolfgang Miesbach: The Critical Need for Tailored Dosing in VWD
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
“Fascinating presentation by Prof. Sophie Susen at the LFB symposium during ISTH 2026, spotlighting the critical need for tailored dosing in von Willebrand disease (VWD)!
Perioperative VWD management is highly complex due to intricate VWF/FVIII dynamics and sheer clinical heterogeneity—truly a ‘kaleidoscope’ of rare subtypes.
Prof. Susen shared valuable insights on the first pharmacokinetic (PK) model developed specifically for pure VWF in this setting:
Bodyweight drives dosing needs: Underweight patients may need up to a 33% dose increase to hit target exposure, while patients with obesity may require a 50% dose reduction to prevent excessive VWF exposure.
Improved prediction accuracy: The novel population PK/PD model successfully integrates key covariates (VWD type, age, body weight, blood type, VWFpp) to predict VWF:Ag levels with high precision.
Fantastic to see decades of real-world evidence translating into actionable clinical tools.
Eagerly anticipating the prospective, multicenter WIL-PKPOP-CHIR validation study beginning enrollment later this year!”

Other posts featuring Wolfgang Miesbach on Hemostasis Today.
-
Nov 15, 2026, 16:29Jean-Jacques Kiladjian: 20 Years of Interferon-Alpha Research in Myeloproliferative Neoplasms
-
Nov 15, 2026, 16:21Sukanto Paul: Why Platelet Transfusion Is Generally Avoided in TTP
-
Nov 15, 2026, 16:14Ahmad G. Alzahrani: Major Bleeding and Anticoagulant Reversal
-
Nov 15, 2026, 16:05Sabine Eichinger: Is Recurrence Risk After Provoked VTE Really Low?
-
Nov 15, 2026, 15:53Nicolas Schommer: The Seed and Soil Hypothesis of NET-Mediated Inflammation
-
Nov 15, 2026, 15:36Giovanni Merlino: Targeting LDL-C to Prevent Recurrent Stroke
-
Nov 15, 2026, 15:33Riitta Lassila: From Helsinki to ISTH 2027 Advancing Thrombosis Research
-
Nov 15, 2026, 15:30Andreas Calatzis: Can Protein C and Plasma Overcome Fibrinolysis Resistance in Sepsis?
-
Nov 15, 2026, 15:25Hussnain Javaid: Thalassaemia 2026 New Therapies Transforming UK Practice